Atlas FDA

InterStim® Therapy System

FDA premarket approval P080025/S316 · decided 2025-09-10

Approval details

PMA number
P080025
Supplement
S316
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
InterStim® Therapy System
Generic name
Implanted electrical device intended for treatment of fecal incontinence
Applicant
Medtronic Neuromodulation
Date received
2025-04-24
Decision date
2025-09-10
Days to decision
139 days
Decision code
APPR
Product code
QON
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
an alternate supplier for the foramen needle component of the lead kit

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23